✦ LIBER ✦

Cost-Effectiveness of Antiplatelet Agents in Secondary Stroke Prevention: The Limits of Certainty

✍ Scribed by David B. Matchar; Gregory P. Samsa; Suping Liu

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Antiplatelet agents for secondary preven

✍ Richard A. Bernstein 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 104 KB

Combination Antiplatelet Agents for Seco

✍ Dr. Joseph P. Vande Griend; Dr. Joseph J. Saseen 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 192 KB

Antiplatelet medications in the secondar

✍ James D. Fleck 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 94 KB

Antiplatelet therapy in secondary stroke

✍ Hans-Christoph Diener; Christian Weimar; Ralph Weber 📂 Article 📅 2010 🏛 Carol Davila University of Medicine Bucharest, Rom 🌐 English ⚖ 468 KB

Cost-effectiveness of apixaban vs warfar

✍ Kamel, H.; Easton, J. D.; Johnston, S. C.; Kim, A. S. 📂 Article 📅 2012 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 578 KB

Antiplatelet drugs in secondary preventi

✍ J Sivenius; M Laakso; PJ Riekkinen Sr 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 123 KB